NASDAQ
ANI Pharmaceuticals, Inc. (ANIP)
♥ 385 Thanks from members
Market sentiment on ANI Pharmaceuticals (ANIP) balances current operational cost pressures and Cortrophin growth execution against attractive risk-reward multiples heading toward expected 2027 inflection points.